Novartis AG Registered Shares (NVSEF)
OTC
Closed
Oct 7, 2026
Day's Range
136.1052 wk Range
120.00Overview - NVSEF - Novartis AG Registered Shares
Key Statistics
Valuation
Enterprise Value
309.72B
P/E (Trailing)
‪21.26‬
PEG Ratio
‪-1.22‬
Price / Sales (TTM)
‪4.72‬
Price / Book
‪6.44‬
EV / EBITDA
‪13.40‬
Profitability
Gross Margin
‪75.18%‬
Profit Margin
‪22.50%‬
Operating Margin
‪34.62%‬
Return on Assets
‪10.25%‬
Return on Equity
‪30.35%‬
Ownership
Shares Outstanding
1.90B
Float
1.85B
Held by Insiders
‪2.11%‬
Held by Institutions
‪46.02%‬
Price stats
Beta
‪0.49‬
50-Day Avg
‪151.82‬
200-Day Avg
‪149.43‬
Dividends
Payout Ratio
‪69.86%‬
Frequency
Annual
Analyst Consensus
1 analysts
Shariah Compliance
Report Date: Feb 18, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - NVSEF - Novartis AG Registered Shares
Peers - NVSEF - Novartis AG Registered Shares
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on OTC.
- NVSEFOTCNovartis AG Registered Shares270.87BMarket Cap+11.61%52-week change21.26P/E (Trailing)‪22.50%‬Profit Margin
- RHHBFOTCRoche Holding AG364.91BMarket Cap+27.84%52-week change24.63P/E (Trailing)‪19.60%‬Profit Margin
- NONOFOTCNovo Nordisk A/S171.32BMarket Cap-43.33%52-week change9.49P/E (Trailing)‪35.34%‬Profit Margin
- GLAXFOTCGSK plc97.17BMarket Cap+20.46%52-week change15.63P/E (Trailing)‪14.52%‬Profit Margin
- SNYNFOTCSanofi SA96.26BMarket Cap-30.80%52-week change21.31P/E (Trailing)‪8.09%‬Profit Margin
- CHGCYOTCChugai Pharmaceutical Co. Ltd.69.41BMarket Cap-1.33%52-week change23.18P/E (Trailing)‪35.10%‬Profit Margin
- BAYRYOTCBayer AG Sponsored ADR56.39BMarket Cap+43.65%52-week change28.38P/E (Trailing)‪-3.83%‬Profit Margin
Profile Summary - NVSEF - Novartis AG Registered Shares
About
Novartis AG is a Swiss multinational pharmaceutical company headquartered in Basel, specializing in innovative medicines across multiple therapeutic areas including cardiovascular, immunology, neuroscience, oncology, and renal and metabolic diseases. The company operates through two primary divisions: Innovative…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
